Insider Selling: Chemed (NYSE:CHE) CEO Sells $1,079,020.00 in Stock

Chemed Corporation (NYSE:CHE) CEO Kevin Mcnamara sold 2,000 shares of the business’s stock in a transaction that occurred on Monday, August 3rd. The stock was sold at an average price of $539.51, for a total value of $1,079,020.00. Following the transaction, the chief executive officer directly owned 70,418 shares in the company, valued at $37,991,215.18. The trade was a 2.76% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Chemed Stock Down 0.8%

CHE traded down $4.55 during midday trading on Tuesday, hitting $536.02. The company had a trading volume of 23,015 shares, compared to its average volume of 221,367. The company has a market capitalization of $7.11 billion, a price-to-earnings ratio of 26.98, a PEG ratio of 2.02 and a beta of 0.51. Chemed Corporation has a 52 week low of $365.20 and a 52 week high of $551.68. The stock’s 50 day moving average price is $469.13 and its 200 day moving average price is $437.15. The company has a quick ratio of 0.89, a current ratio of 0.91 and a debt-to-equity ratio of 0.17.

Chemed (NYSE:CHE) last issued its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 EPS for the quarter, beating analysts’ consensus estimates of $5.60 by $0.46. The company had revenue of $673.25 million during the quarter, compared to the consensus estimate of $665.04 million. Chemed had a return on equity of 31.77% and a net margin of 10.60%.Chemed’s revenue was up 8.8% on a year-over-year basis. During the same period last year, the business posted $4.27 earnings per share. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. On average, research analysts anticipate that Chemed Corporation will post 23.18 earnings per share for the current fiscal year.

Chemed Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th were paid a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date of this dividend was Thursday, May 28th. Chemed’s dividend payout ratio is currently 12.05%.

Wall Street Analyst Weigh In

Several research firms recently commented on CHE. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Royal Bank Of Canada boosted their price target on Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a research note on Thursday. Bank of America reissued a “neutral” rating on shares of Chemed in a research report on Wednesday, July 29th. Oppenheimer increased their target price on shares of Chemed from $500.00 to $590.00 and gave the stock an “outperform” rating in a report on Friday. Finally, Wall Street Zen raised Chemed from a “hold” rating to a “strong-buy” rating in a report on Saturday. One research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $530.75.

Hedge Funds Weigh In On Chemed

Several institutional investors have recently added to or reduced their stakes in CHE. Monetary Solutions Ltd bought a new position in shares of Chemed during the 4th quarter valued at approximately $25,000. Los Angeles Capital Management LLC purchased a new stake in Chemed during the fourth quarter valued at $26,000. BOK Financial Private Wealth Inc. purchased a new position in shares of Chemed in the 4th quarter worth $27,000. Versant Capital Management Inc increased its holdings in shares of Chemed by 7,500.0% in the 2nd quarter. Versant Capital Management Inc now owns 76 shares of the company’s stock worth $35,000 after buying an additional 75 shares during the last quarter. Finally, MassMutual Private Wealth & Trust FSB increased its holdings in shares of Chemed by 65.3% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 81 shares of the company’s stock worth $38,000 after buying an additional 32 shares during the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.